🇺🇲 We’ll be at the American Drug Delivery & Formulation Summit in Boston, 14–15 September. Callavid® is an intravaginal drug delivery platform, at clinical stage with progesterone delivery for threatened miscarriage and IVF support. A further development programme covers locally delivered antibiotics for UTI and AMR. Future applications include gynaecological cancers, menopause-related indications, HIV prophylaxis …

It was great to attend Formulation & Delivery Europe 2026 in Basel last month – a valuable opportunity to explore the latest industry trends in drug formulation and delivery, connect with industry experts to build collaborations, and discuss the technologies shaping the future of healthcare. Innovation is moving quickly in combination products and alternative routes …

We’re delighted to be featured by Technology Networks in this interview with our co-founders, Dr Lara Zibners and Thang Vo-Ta, about our Callavid® intravaginal drug delivery platform. Our first focus is progesterone delivery for threatened miscarriage and IVF– areas where the clinical need is significant, but where the patient experience has too often been overlooked. …

original article here: https://drug-dev.com/expert-content/the-most-underutilized-route-in-drug-delivery-how-vaginal-therapeutics-are-finally-getting-the-platform-they-deserve/ The Most Underutilized Route in Drug Delivery: How Vaginal Therapeutics Are Finally Getting the Platform They Deserve By: Lara Zibners, MD, MMEd, MBA Women are: 51% of the population The majority of prescription drug users (QuickStats, MMWR, 2023) Almost always the medical decision maker for the family (US Dept of Labor) And, …

Original article here by Ben Adams photo by TF-Images/Getty Images German Merck has set up a new collaboration with U.K. medtech company Calla Lily Clinical Care to work on its next-generation intravaginal drug delivery approach. London-based Calla Lily is working on several applications for its Callavid product, a tampon-shaped device that can be used as …

The British menopause society has recently released guidance that women using the ever-so-popular GLP-1 agonists such as Ozempic & Mounjaro, and who are also taking oral progesterone for endometrial protection – should probably be switched to a transdermal or vaginal versions of progesterone. Why? I’ll try to explain via the “cutesy” hashtag making its way …

Things are busy over at Calla Lily Clinical Care! The office is buzzing with all hands-on deck as we prepare for our first in-women trial delivering progesterone via our leak-free Callavid® vaginal drug delivery device. I’m not joking when I saw “all hands-on deck.” Thang Vo-Ta has packed our office to the brim this summer. …

A promising new study published in the BJOG Journal (British Journal of Obstetrics and Gynaecology / Royal College of Obstetricians and Gynaecologists) explores the use of vaginal progesterone for couples facing unexplained infertility. 👀 Could this pave the way for broader use of vaginal progesterone prior to IVF —especially for those who can’t access IVF …

Miscarriage. You can find lots of definitions, from the rather cold  “spontaneous or unplanned expulsion of a fetus from the womb before it is able to survive independently,”  to the softer “sudden loss of a pregnancy before the 20th week.” Either way, it sucks. If you have had one, I’m sorry. So why do women …

When you hear the word “progesterone”, the hormone’s role in fertility treatments may be the first thing that comes to mind. After all, it’s “pro” “gest.” Get it? However, progesterone is not just for women trying to conceive—it also has a critical role in the management of other conditions that affect women throughout their lives. …